WHO Evidence Considerations for Vaccine Policy Development (ECVP)

Overview

WHO’s IVB department has developed a novel kind of guidance for vaccine development stakeholders, referred to as Evidence Considerations for Vaccine Policy, or ECVP.  The ECVP document aims to provide early information on the data and evidence that is likely to be required to support WHO policy recommendations.  The original concept of the ECVP was developed through a global stakeholder meeting (), after which both a generic ECVP framework (posted on this page) and subsequently the first ECVP exemplar has been drafted for new Tuberculosis (TB) vaccines intended for adults and adolescents in collaboration with a global expert technical working group.